Correspondence in reference to the previously published Epub manuscript by Peter Hokland et al. 'How I treat advanced Hodgkin lymphoma – a global view'. Br J Haematol. 2020;190:837–50.

By contrast, the sensitivity rate for lymph node malignant status was 98-8% (95% CI 95-9-99-9%) for PDUS-guided CNB with a false-negative rate of 1-1% (two of 174 patients with lymph nodes positive for malignancy were not identified). The authors emphasised the value of lymph node excisional biopsy as the "gold standard", with the need of a tight partnership with surgical colleagues as part of a multidisciplinary team that can facilitate the surgery excisional biopsy decision-making process. Randomized comparison of power Doppler ultrasound-directed excisional biopsy with standard excisional biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma. [Extracted from the article]